This article gives a brief overview of the current clinical applications in PET/magnetic resonance (MR) imaging in abdominal diseases. Initial technical developments concentrated on improvement of attenuation correction. Significant enhancements have been achieved, which is now considered solved and useable for clinical routine. For clinical applicability, a considerable amount of work was done by several groups to tailor disease-specific protocols for PET/MR imaging. Those protocols focused on providing complementary diagnostic information from the PET as well as from the MR imaging component. Successful protocol implementation has been performed in liver metastases, pancreatic cancer, gynecologic tumors, and especially prostate cancer.
Keywords: Cervical cancer; Hybrid imaging; Liver; Molecular imaging; Neuroendocrine tumor; PET/MR imaging; Pancreatic cancer; Prostate cancer.
Copyright © 2020 Elsevier Inc. All rights reserved.